Jennerex Biotherapeutics Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $150M

Jennerex Biotherapeutics General Information

Description

Developer of oncolytic products intended to treat cancer. The company provides an engineered oncolytic virus that selectively targets and destroys cancer cells and targets the epidermal growth factor, which is engineered from a strain of vaccinia virus.

Contact Information

Website
www.jennerex.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 450 Sansome Street, 16th Floor
  • San Francisco, CA 94111
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
SillaJen
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 450 Sansome Street, 16th Floor
  • San Francisco, CA 94111
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jennerex Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 18-Mar-2014 $150M Completed Generating Revenue
9. Accelerator/Incubator 14-Jun-2024 Completed Generating Revenue
8. Later Stage VC 23-May-2013 Completed Generating Revenue
7. Later Stage VC 11-Oct-2011 Completed Generating Revenue
6. Later Stage VC 06-Sep-2011 Completed Generating Revenue
5. Later Stage VC (Series C) 18-Sep-2009 Completed Generating Revenue
4. Grant 11-Jun-2009 Completed Generating Revenue
3. Later Stage VC (Series B) 09-Sep-2008 Completed Generating Revenue
2. Early Stage VC (Series A) 24-May-2007 $1.71M $9.7M Completed Product Development
1. Seed Round $8M $8M Completed Product Development
To view Jennerex Biotherapeutics’s complete valuation and funding history, request access »

Jennerex Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oncolytic products intended to treat cancer. The company provides an engineered oncolytic virus that select
Drug Discovery
San Francisco, CA

Boston, MA
 

Santa Monica, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Jennerex Biotherapeutics Competitors (57)

One of Jennerex Biotherapeutics’s 57 competitors is Vor Biopharma, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vor Biopharma Formerly VC-backed Boston, MA
Kite Pharma Formerly VC-backed Santa Monica, CA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Nkarta Therapeutics Formerly VC-backed South San Francisco, CA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
You’re viewing 5 of 57 competitors. Get the full list »

Jennerex Biotherapeutics Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Jennerex Biotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1578396-A2 Methods and compositions concerning poxviruses and cancer Inactive 12-Aug-2002
EP-1578396-A4 Methods and compositions concerning poxviruses and cancer Inactive 12-Aug-2002

Jennerex Biotherapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
GC Biopharma Corporation Minority
QB3 Accelerator/Incubator
Transgene Biotek Corporation Minority
To view Jennerex Biotherapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Jennerex Biotherapeutics FAQs

  • When was Jennerex Biotherapeutics founded?

    Jennerex Biotherapeutics was founded in 2003.

  • Where is Jennerex Biotherapeutics headquartered?

    Jennerex Biotherapeutics is headquartered in San Francisco, CA.

  • What industry is Jennerex Biotherapeutics in?

    Jennerex Biotherapeutics’s primary industry is Drug Discovery.

  • Is Jennerex Biotherapeutics a private or public company?

    Jennerex Biotherapeutics is a Private company.

  • What is the current valuation of Jennerex Biotherapeutics?

    The current valuation of Jennerex Biotherapeutics is .

  • What is Jennerex Biotherapeutics’s current revenue?

    The current revenue for Jennerex Biotherapeutics is .

  • How much funding has Jennerex Biotherapeutics raised over time?

    Jennerex Biotherapeutics has raised $55.6M.

  • Who are Jennerex Biotherapeutics’s investors?

    GC Biopharma, QB3, and Transgene Biotek have invested in Jennerex Biotherapeutics.

  • Who are Jennerex Biotherapeutics’s competitors?

    Vor Biopharma, Kite Pharma, CytomX Therapeutics, Nkarta Therapeutics, and Adaptimmune Therapeutics are some of the 57 competitors of Jennerex Biotherapeutics.

  • When was Jennerex Biotherapeutics acquired?

    Jennerex Biotherapeutics was acquired on 18-Mar-2014.

  • Who acquired Jennerex Biotherapeutics?

    Jennerex Biotherapeutics was acquired by SillaJen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process